Pharmaceuticals - Indian - Formulations
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 128.11 | 82.98 | 52.31 | - | - |
Total Expenses | 119.52 | 79.53 | 50.80 | - | - |
Profit Before Tax | 8.59 | 3.44 | 1.51 | - | - |
Profit After Tax | 6.31 | 2.51 | 1.39 | - | - |
Operating Profit after Depreciation | 9.11 | 3.92 | 1.97 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 2.69 | 3.97 | 2.98 | - | - |
Total Non Current Assets | 9.80 | 8.28 | 5.70 | - | - |
Total Current Assets | 11.95 | 6.43 | 6.69 | - | - |
TOTAL ASSETS | 21.75 | 14.71 | 12.39 | - | - |
Total Shareholder's Fund | 9.43 | 3.27 | 0.77 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 7.04 | - | - | - | - |
Net Cash used in Investing Activities | -2.61 | - | - | - | - |
Net Cash used in Financing Activities | -2.57 | - | - | - | - |
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Sat Kartar Shopping Ltd | ₹164.60 | ₹259.16 |
Sun Pharmaceuticals Industries Ltd | ₹1,613.65 | ₹3,87,168.69 |
Divis Laboratories Ltd | ₹5,725.20 | ₹1,51,986.07 |
Cipla Ltd | ₹1,463.25 | ₹1,18,174.12 |
Torrent Pharmaceuticals Ltd | ₹3,028.40 | ₹1,02,490.21 |
Mankind Pharma Ltd | ₹2,337.05 | ₹96,421.67 |
Shares of Sat Kartar Shopping were trading at Rs 161.55 on the BSE, a premium of 99.44% compared with the issue price of Rs 81.
17 Jan 2025, 11:47 am